Israel Englander Repligen Corp Call Options Transaction History

Millennium Management LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$119.79 - $167.35 $371,349 - $518,785	3,100 Added 6.14%	53,600 $7.98 Million
Q2 2024 Aug 14, 2024	BUY	$120.0 - $182.95 $6.06 Million - $9.24 Million	50,500 New	50,500 $6.37 Million
Q2 2023 Aug 14, 2023	SELL	$138.42 - $180.31 $2.05 Million - $2.67 Million	-14,800 Reduced 74.0%	5,200 $735,000
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $10.2 Million - $13.1 Million	-66,000 Reduced 76.74%	20,000 $3.37 Million
Q4 2022 Feb 14, 2023	BUY	$162.42 - $220.56 $14 Million - $19 Million	86,000 New	86,000 $14.6 Million

489

54.3M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.14B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.